Hospitals Weigh ROI of RFID and RTLS for Smarter Medication Management
Drug shortages continue to create significant financial and operational strainRead More
Ascensia to Transfer Eversense CGM Commercial Operations to Senseonics
Image Credit: Adobe Stock Images/Jordi.com Ascensia Diabetes Care—a part ofRead More
How Model-Informed Tools Drive Cost, Speed and Access
Sharmeen Roy, PharmD, BCPS The pharmaceutical industry’s digital shift nowRead More
Transforming Hospital Pharmacy Inventory Management
Drug shortages continue to create significant financial and operational strainRead More
Amgen Invests $600M in Innovation Hub, Novartis Collaborates With Argo, and Wegovy Tops Tirzepatide in Heart Outcomes
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
AI’s New Role in Pharma Strategy
Avinob Roy, Vice President & General Manager of Global CommercialRead More
Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power
Image Credit: Adobe Stock Images/Philip.com Last night, the Trump administrationRead More
Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation
Image Credit: Adobe Stock Images/SundryPhotography.com Gilead Sciences has unveiled itsRead More
How Drug Shortages Could Disrupt Hospital Operations and Strain Patient Care
Drug shortages continue to create significant financial and operational strainRead More
Trump Appeals Tariff Ruling, Sanofi Shares Slide on Trial Miss, and COVID-19 Alters Pneumococcal Mortality
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Overcoming Barriers to Full e-Prescribing Adoption
The Prescription Information Modernization Act of 2025 (PIMA) is beingRead More
Amgen Invests $600M in Innovation Hub, Novartis Buys Argo for $5.2B, and Wegovy Tops Tirzepatide in Heart Outcomes
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Why Reducing Paper Inserts Is About Access as Much as Sustainability
The Prescription Information Modernization Act of 2025 (PIMA) is beingRead More
FDA Approves Sanofi’s Wayrilz, OTC Triptans Show Public Health Gains, and Biosimilar Rules Streamlined
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Modernizing Prescription Information
The Prescription Information Modernization Act of 2025 (PIMA) is beingRead More
Flu Vaccination Rates Improve, AI Powers RNA Therapeutics, and Statin Intolerance Spurs Self-Medication Risks
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Pharma Supply Chain Faces Risks of Tariffs Driving Excess Inventory
In a video interview with Pharma Commerce, Dave Malenfant, aRead More
Child Vaccines Show Adult Protection, Lilly Pauses Mounjaro Shipments, and FDA Rejects Lytenava Resubmission
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
The Great Pharma Reshoring
This video was created based on various Pharma Commerce articles:Read More
CDC Director Pushback, Persistent Drug Shortages, and FDA Clears First Generic GLP-1 for Weight Loss
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Mitigating Pharmaceutical Supply Chain Challenges
Thani Jambulingam, PhD, professor of food, pharma, and healthcare businessRead More
Pharmaceutical Commerce Presents The Most Favored Nation Mandate
Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! EarlierRead More
Eli Lilly Pauses UK Mounjaro Shipments Ahead of 170% Price Hike
Image Credit: Adobe Stock Images/KKStock.com With an increase in priceRead More
Cold Chain Technologies Expands APAC Presence With New Hubs, Distributors, and Manufacturing Investment
Image Credit: Cold Chain Technologies Cold Chain Technologies (CCT), isRead More
Balancing Tariffs and Patient Access in Pharma Policy
In a video interview with Pharma Commerce, Dave Malenfant, aRead More
ACOG Reaffirms COVID-19 Vaccine in Pregnancy, SGLT2 Real-World Safety Data, and EVERSANA–Waltz Tackle Drug Costs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
FDA Greenlights New COVID Vaccines, Sets Eligibility Limits
Credit: Tada Images | stock.adobe.com The FDA has authorized theRead More
FDA Boosts Transparency, CDC Appoints mRNA Critic, and Genentech Invests $700M in US Manufacturing
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
AI Fuels Surge in Counterfeit Drug Websites
In a video interview with Pharma Commerce, Mark Lee, MarqVision’sRead More
Novo Nordisk Plant Faces FDA Scrutiny, Off-Label GLP-1 Use Grows, and AbbVie Expands Psychiatry Pipeline
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Novo Nordisk’s Indiana Plant Flagged by FDA for Contamination and Safety Lapses
Image Credit: Adobe Stock Images/TadaImages.com Novo Nordisk has some facilityRead More
Top Questions Regarding the DSCSA
Image Credit: Adobe Stock Images/DreamerStudio.com DSCSA stands for the DrugRead More
Johnson & Johnson Commits $2 Billion to North Carolina Manufacturing Expansion
Image Credit: Adobe Stock Images/MichaelVi.com Johnson & Johnson is all inRead More
Combating Counterfeit Medicines Requires AI Integration and Industry Collaboration
In a video interview with Pharma Commerce, Mark Lee, MarqVision’sRead More
Pharma Tariffs Take Shape, J&J Invests $2 Billion in US Manufacturing, and New EHR Rule Targets Prior Authorization
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
CVS Caremark Ordered to Pay $290 Million in False Claims Act Whistleblower Case
Image Credit: Adobe Stock Images/ImagingL.com Following an eight-day bench trial,Read More
Building the Next-Generation Supply Chain Talent Pipeline (Episode 9)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Pharma Regulatory Strategies Could Shift as Vaccine Support Declines
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner atRead More
White House and EU Finalize Trade Deal With 15% Cap on Pharma Tariffs
Image Credit: Adobe Stock Images/Aquir.com As noted by Pharm Exec,1Read More
Catalent Layoffs, Diabetes Tech Adoption, and Long-Term Heart Risks from Childhood COVID-19
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
New Technologies Drive Down Pharma Manufacturing Costs in the United States
In a video interview with Pharma Commerce, Dave Malenfant, aRead More
Agile Drug Manufacturing Advances, Merck–Skyhawk RNA Deal, and Telehealth Expands Pharmacists’ Role
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
AI-Powered Tools Transform Fight Against Counterfeit Drugs
In a video interview with Pharma Commerce, Mark Lee, MarqVision’sRead More
Wegovy Wins Accelerated Approval, New Flu Combo Emerges, and Community Pharmacies Expand Access
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Counterfeiters Target Fragmented Pharma Supply Chains Through Digital Marketplaces
In a video interview with Pharma Commerce, Mark Lee, MarqVision’sRead More
GLP-1 Access Partnership, Pfizer’s Sickle Cell Setback, and Patient Portal Trade-Offs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Gross-to-Net Bubble Reshapes Drug Pricing Strategy
This video was created based on Bill Roth’s “Popping theRead More
Goodpath Partners With GiftHealth to Expand Access to GLP-1 Therapies Through LillyDirect
Image Credit: Adobe Stock Images/Thanayut.com Goodpath, a virtual clinic forRead More
Pharma Leaders Stress Tailored, Balanced Approach to Long-Term Manufacturing Strategy (Episode 8)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
US API Stockpile Plan, Mounjaro Price Hike in UK, and New Data on Vaccine Safety
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Pharmaceutical Commerce: August 2025 Interactive Digital Edition
View the Pharmaceutical Commerce August 2025 issue in an interactiveRead More
AbbVie Boosts Domestic API Manufacturing, Supermarkets Lead in Pharmacy Satisfaction, and GLP-1 Coverage Tightens
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
AI-Powered Counterfeit Drug Schemes Pose Growing Threat to Patient Safety
In a video interview with Pharma Commerce, Mark Lee, MarqVision’sRead More
Cardinal Health Expands with Solaris Acquisition, Hospitals Centralize Pharmacy Hubs, and GLP-1 Safety Signals Emerge
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Potential 250% Pharma Tariffs Could Pressure Margins Without Directly Raising Patient Costs
In a video interview with Pharma Commerce, Dave Malenfant, aRead More
Insurance Barriers Delaying Patient Care
Key Takeaways Patient access to treatment remains poor. For theRead More
Balancing AI Ambition With Cost Pressures in Pharma
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceuticalRead More
Pharma Pulse: Redefining the Pharmacy Aisle
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where weRead More
Ways Pharma Supply Chains Can Cut Scope 3 Emissions Now
In a video interview with Pharma Commerce, Heather Zenk, Cencora’sRead More
a client-side exception has occurred
Application error: a client-side exception has occurred (see the browserRead More
Lessons From Shortages and Global Disruptions
In a video interview with Pharma Commerce, Heather Zenk, Cencora’sRead More
Esteve Expands US Footprint With Acquisition of Regis Technologies, Boosts Rare Disease Portfolio
Image Credit: Adobe Stock Images/JozefMicic.com Esteve has purchased Regis Technologies,Read More
Pharma Industry Shifts Toward Full Activation
In a video interview with Pharma Commerce, Heather Zenk, Cencora’sRead More
Adapting to a Changing Research Funding Landscape; Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
Adapting to a Changing Research Funding Landscape In an interviewRead More
Balancing Compliance and Supply Chain Continuity
In a video interview with Pharma Commerce, Heather Zenk, Cencora’sRead More
How Grocery-Based Pharmacies are Evolving into Community Health Hubs
Image Credit: Adobe Stock Images/AMuhSakaria.com As large pharmacy retailers scaleRead More
FDA Delays Regeneron’s Odronextamab, Eylea HD Regulatory Decisions Over Catalent Site Issues
Credit: Ascannio | stock.adobe.com. The FDA has issued a secondRead More
Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response
As reported by Pharma Commerce sister publication, Pharmaceutical Executive,1 PresidentRead More
Leveraging Technology to Strengthen Pharma’s Fight Against Counterfeits (Episode 6)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
What Clinical Ops Teams Must Know About Biomarkers in Trials; What is the Timeline for True AI Implementation for Digital Twins?
What Clinical Ops Teams Must Know About Biomarkers in TrialsRead More
Emission-Reduction Strategies That Save Money and Preserve Performance
In a video interview with Pharma Commerce, Nate Chenenko, principalRead More
High Out-of-Pocket Costs Burden Privately Insured Cancer Patients, Study Finds
With there being challenges in analyzing OOPCs that were relatedRead More
Tackling ESG Data Gaps in Supplier and Third-Party Reporting
In a video interview with Pharma Commerce, Nate Chenenko, principalRead More
United States, European Union Reach Trade Pact
President Trump reached a formal trade agreement with the EuropeanRead More
Weighing Cost Savings Against Safety and Regulatory Risks
In a video interview with Pharma Commerce, Hyung Heon Kim,Read More
Rethinking Oncology Trials with a Statistical Methodology That Puts Patients First; How Can Real World Data and AI Help Solve Issues with Clinical Trials?
Rethinking Oncology Trials with a Statistical Methodology That Puts PatientsRead More
Unlocking Sustainability Across the Supply Chain
In a video interview with Pharma Commerce, Nate Chenenko, principalRead More
Recapping the Sarepta Saga—And Implications for Industry
The controversy surrounding embattled gene therapy company Sarepta Therapeutics, includingRead More
Balancing DEI Reporting with Legal Risk; What the Emrelis Approval Means for Pharma and Biotech ADC Strategies
Balancing DEI Reporting with Legal Risk In an interview withRead More
How Pharma Executives Can Prepare for Tariff Uncertainty
In a video interview with Pharma Commerce, Brad Stewart, BDO’sRead More
How Life Sciences Firms Are Evolving to Navigate Trade, Tariff, and Pricing Turbulence
Sixty percent of life sciences and healthcare leaders are anticipatingRead More
Supply Chain Blind Spots Threatening Pharma Integrity (Episode 5)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Cold Chain Technologies, E&I Cooperative Services Strike Deal to Provide Schools with Expedited Access to Cold Chain Solutions
Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access:Read More
Leveraging Digital Twins and Analytics to Optimize Global Pharma Supply Chains
In a video interview with Pharma Commerce, Brad Stewart, BDO’sRead More
Driving Adherence and Safety Through Digital Innovation
Patient safety and medication adherence are some of the majorRead More
EU Threatens 30% Tariffs on $117 Billion of US Goods Amid Trade Standoff
The European Union intends to impose a 30% tariff onRead More
Building Inventory and Navigating FDA Hurdles in a Tariff-Driven Market
In a video interview with Pharma Commerce, Brad Stewart, BDO’sRead More
The Ripple Effect of 200% Tariffs on US Drug Supply and Pricing
In a video interview with Pharma Commerce, Brad Stewart, BDO’sRead More
Knipper Health Purchases eBlu Solutions to Accelerate Therapy Initiation
The combination of both parties’ offerings is a platform forRead More
Balancing Awareness and Assurance
In a video interview with Pharma Commerce, Sean O’Hearen, founderRead More
Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research; Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Treatment
Inside the GLP-1 Strategy Driving Competitive Edge in Obesity ClinicalRead More
Cracking Down on Illegal Online Pharmacies
In a video interview with Pharma Commerce, Sean O’Hearen, founderRead More
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies; Eisai Explores Novel Dual Mechanism Therapy for Advanced Endometrial Carcinoma
How Parexel Supports Cross Functional Trials for Emerging GLP-1 TherapiesRead More
The Hidden Challenge of Reporting Counterfeit Medicines
In a video interview with Pharma Commerce, Sean O’Hearen, founderRead More
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
Resilience, which is the concept of defying adversity and recoveringRead More
How DSCSA Is Transforming Supply Chain Data Exchange (Episode 4)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Trump Says Pharma Industry Should Expect Tariffs by Aug. 1
President Trump noted that the pharma sector should prepare forRead More
Creating a Unified Strategy to Advance Education on Counterfeit Medicines
In a video interview with Pharma Commerce, Sean O’Hearen, founderRead More
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
Image Credit: Adobe Stock Images/ASDF Key Takeaways Strategic site acquisition:Read More
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
The consortium will be focused on deploying novel technologies toRead More
Why Medical Education Must Catch Up
In a video interview with Pharma Commerce, Sean O’Hearen, founderRead More
LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim
LEO Pharma will pay Boehringer Ingelheim $105.2 million (€90 million)Read More
Knipper Health Taps Willis Chandler as New President and CEO
Chandler’s pharmaceutical experience spans years in the pharma services space,Read More
Gilead, Global Fund Partner to Expand Access to Lenacapavir
Gilead plans to supply enough doses to assist up toRead More
Removing Financial Barriers to Boost Trial Diversity; How Prescribing Power Has Shifted Beyond Physicians
Removing Financial Barriers to Boost Trial Diversity In an interviewRead More
How Pharma Can Detect Supply Chain Failures Before They Happen (Episode 3)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
Despite these medications being both available and affordable, racial, ethnic,Read More
A Look Under the Hood of Medicaid Support
In a video interview with Pharma Commerce, Marschall Runge, MD,Read More
Why Every Employee Needs to Be Part of the Journey
Few times in the evolution of a pharmaceutical company areRead More
Sustaining Regulatory Engagement Through Industry and Advocacy Collaboration
PC: In the absence of public participation at the federalRead More
Navigating Market Entry Challenges for Orphan Drugs
July 9, 2025 Edward Ahn, CEO of MEDIPOST, Inc., reactsRead More
Pharma Industry Should Brace for up to 200% Tariffs
President Trump noted that import taxes on pharmaceuticals of upRead More
What Payers Really Want from High Cost Therapies in Rare Diseases
PC: How might this change affect payer negotiations and reimbursementRead More
Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations
All of the levies come with a stipulation—if these nationsRead More
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
A qualitative study explored how representatives from MA plans, kidneyRead More
Aligning Real-World Evidence with Payer Perspectives
The trust gap between real-world evidence (RWE)/data and randomized controlledRead More
Building Patient Centricity into Clinical Trial Software from Day One; Industry Voices on Current Pricing and Reimbursement Models
2025 DIA Annual Meeting: Building Patient Centricity into Clinical TrialRead More
Patient Engagement Is Critical to Developing Breakthrough Treatments
PC: What risks do you foresee for companies developing first-in-classRead More
Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research
Preparing for Federal Regulations: Q&A with John Stanford In anRead More
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials
Oncology Care Index Spurs J&J to Address Fragmentation in CancerRead More
The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts
The Impact of FDA’s Ban on Compounded GLP-1s A PharmaceuticalRead More
Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030
This investment exemplifies Hikma’s interest in raising the volume ofRead More
The Evolution of the CGT Launch and Distribution Model
In a video interview with Pharma Commerce, Mark Sawicki, PhD,Read More
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
Historically, new drugs were approved for a single therapeutic use.Read More
Medicaid’s Role in the CGT Sector
Medicaid is especially critical for children with rare diseases, dueRead More
How Patient Advocacy Is Guiding Rare Disease Drug Development
PC: What role has public participation historically played in shapingRead More
Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership
Novo Nordisk is growing coverage of its Wegovy injection 2.4Read More
Delivering Value Beyond the Trial with Real-World Evidence
Real-world evidence (RWE) is no longer optional—it’s expected. This episodeRead More
The Importance of Early Patient Feedback in Digital Endpoint Development; Developing FP&A Strategies in Today’s Environment
2025 DIA Annual Meeting: The Importance of Early Patient FeedbackRead More
Supply Chain Planning in the Current CGT Climate
In a video interview with Pharma Commerce, Mark Sawicki, PhD,Read More
How CRO Partnerships Are Evolving to Meet Changing Industry Demands; Don’t Fall for the Call of Placebo-Controlled Vaccine Trials
How CRO Partnerships Are Evolving to Meet Changing Industry DemandsRead More
How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials; The Role of Patient Advocacy in Shaping AbbVie’s Cancer Therapies
2025 DIA Annual Meeting: How AI and Machine Learning CanRead More
Discovering AI’s Role in Drug Safety Monitoring
Pharmaceutical Commerce: FDA staff cuts have created a critical gapRead More
Developing a Manufacturing Contingency Plan (Episode 2)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Utilizing AI in Today’s Current Landscape
In a video interview with Pharma Commerce, Mark Sawicki, PhD,Read More
Does Risk-Based Payment Drive Better Care in Medicare Advantage?
Investigators aimed to examine the quality and efficiency under theRead More
Overcoming Regulatory Barriers to Market Access
As international price referencing tightens and payer expectations rise, companiesRead More
Xcellbio, Thermo Fisher Team up to Advance Cell Therapy Manufacturing
The purpose of the partnership is to help further developRead More
The Hidden Costs of Zero-Premium Plan Turnover
Image Credit: Adobe Stock Images/TadaImages.com As a result of theRead More
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Stop Losing Patients at the Gate: The 24-Hour Window ThatRead More
Evaluate Issues Annual World Preview Report
Image Credit: Adobe Stock Images/StockMediaLabs.com Evaluate, who provides market insightsRead More
Current Perspective on Pricing and Reimbursement Models
This Peer Exchange® starts off with an introduction of theRead More
June 2025 Interactive Digital Edition
Pharmaceutical Commerce: June 2025 Interactive Digital Edition DSCSA Compliance: TheRead More
Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research
Strategic Planning in the Rebate Economy: What Pharma Must DoRead More
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success InRead More
Antares Vision Group Debuts AI-Powered Visual Inspection Platform
AI-GO blister inspection. Image Credit: Antares Vision Group Antares VisionRead More
Understanding the Pharma Supply Chain (Episode 1)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of PharmaceuticalRead More
Establishing Additional Transparency
In a video interview with Pharma Commerce, LeAnn Boyd, PharmD,Read More
How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress
Image Credit: Adobe Stock Images/DigitalMagicVisions.com One of several public healthRead More
TekniPlex Healthcare Unveils New Barrier Protection Systems Plant
TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, andRead More
The Impact of Initial Coverage Choice
Image Credit: Adobe Stock Images/Rawpixel.com Data show that nearly two-thirdsRead More
Changing the PAP Model
The advantages and challenges associated with structuring a patient assistanceRead More
Bolstering Health Technology Assessment With the Help of AI
Key Takeaways AI enhances traditional HTA by improving accuracy andRead More
Policy Whiplash? 24 Hours in the Hub Still Matters More
Key Takeaways Speed is Critical. The first 24 hours afterRead More
Raising the Alarm
Key Takeaways Lack of Awareness Among Healthcare Providers. Despite beingRead More
What Is Smart Pharma Packaging?
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’sRead More
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA; Do We Really Pay More for Prescription Drugs in the United States?
Navigating the Intersection of Accessibility and Measurement Integrity in eCOARead More
Embedded Product Intelligence’s Role in Maintaining Cold Chain Integrity
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’sRead More
Reviewing the Most-Favored Nation Model
Key Takeaways Reintroduction of the MFN model. The Trump AdministrationRead More
Addressing the Threat of Prescription Abandonment
Sticker shock at the pharmacy counter has become an all-too-familiarRead More
Extreme Examples of Who Grew the Bubble
Key Takeaways Price hikes, not launch prices, drove the GTNRead More
DHL Officially Obtains CRYOPDP
Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquiredRead More
Financial Assistance Programs and Healthcare Plan Navigation
June 12, 2025 Amy Niles, chief mission officer, PAN Foundation,Read More
Using Data to Influence Drug Pricing Policy
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’sRead More
The Financial Burden of Alzheimer’s Disease and Related Dementias
Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affectsRead More
Bridging Access Gaps
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’sRead More
The Connection Between Virtual Care and Language Barriers
Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduceRead More
How MFN Executive Order Could Affect International Drug Costs
PC: Although ways to decrease healthcare costs are certainly encouragedRead More
Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season
Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shippingRead More
Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health
Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature,Read More
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens
Five Critical Challenges in Investigator Site Selection and How ClinicalRead More
How Geospatial Mapping Reveals the Impact of Pharmacy Closures
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’sRead More
GLP-1 Drugs May be Linked to Elevated Risk of Serious Eye Disease; Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
GLP-1 Drugs may be Linked to Elevated Risk of SeriousRead More
Mapping the Hidden Costs
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’sRead More
The Variation in Dual-Eligible Beneficiary Characteristics across Medicare Advantage Plan Types
Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment amongRead More
BioNTech, BMS to Co-Design and Co-Commercialize New Antibody Candidate for Various Types of Tumors
Image Credit: Adobe Stock Images/Hugnaka.com Key Takeaways BioNTech and BristolRead More
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma
Forging a Brighter Future for Rare Disease Outcomes with SpecialtyRead More
Driving Supply Chain Resilience
In a video interview with Pharma Commerce, Scott Tillman, Logility’sRead More
Greater Supply Chain Prepares for Repercussions
Image Credit: Adobe Stock Images/Somneuk.com Key Takeaways Tariffs could spikeRead More
Overcoming Legacy Systems
In a video interview with Pharma Commerce, Scott Tillman, Logility’sRead More
Why CX Is a Difference Maker for Pharma
Key Takeaways Exceptional CX significantly boosts engagement with healthcare professionalsRead More
Bora Expands Baltimore Facility, Adds Automated Fill-Finish Line
Image Credit: Adobe Stock Images/KevinRuck.com Key Takeaways To meet risingRead More
Amplifying Workforce Development
In a video interview with Pharma Commerce, Scott Tillman, Logility’sRead More
Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan
May 28th 2025 Article When a South Korean patient neededRead More
Modeling Shared Decision-Making in Patient Communications
When Coretta learned she had stage 4 non-small cell lungRead More
Marken’s Precision Logistics Accelerate Life-Changing Therapy Delivery to Patient in South Korea
May 28th 2025 Article Tasked with the delivery of twoRead More
Mercalis and PharmaCord Officially Merge, Form Valeris
Image Credit: Adobe Stock Images/Feodora.com Main Takeaways The merger ofRead More
Being Digitally Optimized
In a video interview with Pharma Commerce, Scott Tillman, Logility’sRead More
How Recent Executive Orders Impact the Drug Pricing Landscape
In this exclusive PC Podcast interview, Alice Valder Curran, partner at HoganRead More
Bridging the GenAI Adoption Gap in Supply Chain
In a video interview with Pharma Commerce, Scott Tillman, Logility’sRead More
FDA Grants Interchangeability Designation to Hadlima
Image Credit: Adobe Stock Images/PostModernStudio.com Key Takeaways Full interchangeability approved:Read More
Why It’s Time to Upgrade, and What’s at Stake
The pharmaceutical industry stands at the threshold of a long-overdueRead More